(Q46029457)

18 December 2017

title

Ambulatory blood pressure control with bedtime aspirin administration in subjects with prehypertension. (English)

1 reference

18 December 2017

1 reference

1 reference

4

1 reference

18 December 2017

author name string

Ramón C Hermida

series ordinal

1

1 reference

18 December 2017

Diana E Ayala

series ordinal

2

1 reference

18 December 2017

Artemio Mojón

series ordinal

3

1 reference

18 December 2017

publication date

30 April 2009

1 reference

18 December 2017

Journal of Clinical Hypertension

published in

1 reference

18 December 2017

volume

22

1 reference

18 December 2017

page(s)

896-903

1 reference

18 December 2017

issue

8

1 reference

18 December 2017

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.83

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.83

Cardiovascular Outcome in Relation to Progression to Hypertension in the Copenhagen MONICA Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.83

Feasibility of treating prehypertension with an angiotensin-receptor blocker

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.83

The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.83

Studying interventions to prevent the progression from prehypertension to hypertension: does TROPHY win the prize?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.83

2007 Guidelines for the Management of Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.83

Aspirin administered at bedtime, but not on awakening, has an effect on ambulatory blood pressure in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.83

Antioxidative properties of acetylsalicylic Acid on vascular tissues from normotensive and spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.83

Prevention of angiotensin II-induced hypertension, cardiovascular hypertrophy and oxidative stress by acetylsalicylic acid in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.83

Aspirin protects endothelial cells from oxidant damage via the nitric oxide-cGMP pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.83

Aspirin induces nitric oxide release from vascular endothelium: a novel mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.83

Effects of cyclooxygenase and lipoxygenase inhibitors on digoxin-induced arrhythmias and haemodynamics in guinea-pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.83

Administration time-dependent influence of aspirin on blood pressure in pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.83

Prospective, randomized, open-label, blinded-endpoint (PROBE) designed trials yield the same results as double-blind, placebo-controlled trials with respect to ABPM measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.83

Administration-time-dependent effects of doxazosin GITS on ambulatory blood pressure of hypertensive subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.83

Differing administration time-dependent effects of aspirin on blood pressure in dipper and non-dipper hypertensives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.83

Circadian variation of blood pressure and endothelial function in patients with essential hypertension:a comparison of dippers and non-dippers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.83

Chronotherapy of hypertension: administration-time-dependent effects of treatment on the circadian pattern of blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.83

A specialist in clinical hypertension critiques the TROPHY trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.83

7 January 2021

Clinical pharmacology of platelet cyclooxygenase inhibition

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.83

7 January 2021

Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: rationale and design of the MAPEC study

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.83

7 January 2021

Influence of aspirin usage on blood pressure: dose and administration-time dependencies

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.83

7 January 2021

A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.83

7 January 2021

Circadian variation in vascular tone and its relation to alpha-sympathetic vasoconstrictor activity.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.83

7 January 2021

Cyclooxygenase-2 inhibition decreases renin content and lowers blood pressure in a model of renovascular hypertension

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.83

7 January 2021

Day-night variations in blood levels of nitric oxide, T-TFPI, and E-selectin

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.83

7 January 2021

Prospective randomized open blinded end-point (PROBE) study. A novel design for intervention trials. Prospective Randomized Open Blinded End-Point

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.83

7 January 2021

Identifiers

DOI

10.1038/AJH.2009.83

1 reference

18 December 2017

PubMed ID

19407805

1 reference

18 December 2017